l General Information |
Product Name | Lonidamine |
General description | Lonidamine is an orally administered small molecule hexokinase inactivator. |
Synonym | AF 1890, Diclondazolic Acid; 1-[(2,4-dichlorophenyl)methyl]indazole-3-carboxylic acid |
Purity | ≥98.0%(HPLC) | CAS Number | 50264-69-2 |
Formula | C15H10Cl2N2O2 | Molecular Weight | 321.157 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Off-White to Yellow Solid |
Solubility(25°C) | DMSO | ≥50mg/mL |
Ethanol | Insoluble |
Water | Insoluble |
l Biological Information |
Biochem/Physiol
Actions | Lonidamine is an indazole carboxylic acid derivative that exhibits radiosensitizing and antiparasitic effects and interferes with the multidrug resistance mechanism. |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
